Fox Chase Cancer Center-Rockledge — Rockledge, Pennsylvania

Fox Chase Cancer Center-Rockledge is a clinical research site located in Rockledge, Pennsylvania, United States 19046.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Fox Chase Cancer Center-Rockledge has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Non-muscle-invasive Bladder Cancer, Recurrent Non-Muscle Invasive Bladder Carcinoma, Stage 0a Bladder Cancer AJCC v8.

Sponsors: ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Rockledge

Browse all research sites in Pennsylvania · View every site in Rockledge

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fox Chase Cancer Center-Rockledge?

Fox Chase Cancer Center-Rockledge has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fox Chase Cancer Center-Rockledge conducted?

Fox Chase Cancer Center-Rockledge has 2 clinical trials on record, with 2 currently active. Their work covers Non-muscle-invasive Bladder Cancer, Recurrent Non-Muscle Invasive Bladder Carcinoma, Stage 0a Bladder Cancer AJCC v8.

Is Fox Chase Cancer Center-Rockledge accredited by Crixeo Clinical Trials?

Fox Chase Cancer Center-Rockledge has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fox Chase Cancer Center-Rockledge?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.